In addition, studies showed that TMEM16A gene amplification and protein overexpression affect the clinical outcomes of HNSCC patients (Ruiz et al., 2012), especially HPV-negative HNSCC patients (Dixit et al., 2015). The gene discussed is ANO1; the disease is head and neck squamous cell carcinoma.